The current institutional shareholding score of Xeris Biopharma Holdings Inc is 5.00, ranking 73 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 57.26%, representing a quarter-over-quarter decrease of 4.21%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.26% of shares outstanding, with 0.88% decrease in holdings.